Zomib-based nanomicellar formulation and preparation method therefor
WO2026103292A1PCT designated stage Publication Date: 2026-05-21JIANGSU BIOSCENE PHARMACEUTICAL CO LTD
View PDF 6 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- JIANGSU BIOSCENE PHARMACEUTICAL CO LTD
- Filing Date
- 2025-09-08
- Publication Date
- 2026-05-21
Smart Images

Figure CN2025119570_21052026_PF_FP_ABST
Abstract
Provided are a zomib-based nanomicellar formulation and a preparation method therefor. The nanomicellar formulation comprises: carfilzomib, a micelle carrier material, and a stabilizer, wherein the mass ratio of carfilzomib, the micelle carrier material, and the stabilizer is 1:15-30:15-30, and the carrier material is PEG-DSPE. PEG-DSPE is used as a drug carrier to prepare a carfilzomib micelle formulation. The formulation has a particle size of 8-20 nm, has high entrapment efficiency, and has a strong cell penetration capability without being quickly cleared. In addition, the preparation process is simple, without requiring lyophilization. Compared with existing cafilzomib formulations, the toxicity is reduced at the same dosage.
Need to check novelty before this filing date? Find Prior Art